Study ID: BDB-AS-302 | 2013-004632-30
Study Title
- A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma
Teva Identifier
- BDB-AS-302 | 2013-004632-30
ClinicalTrials.gov Identifier
- NCT02040766
Study Status
- Completed
Trial Condition(s)
- Asthma
Interventions
- Drug: Beclomethasone dipropionate BAI | Drug: Placebo BAI | Drug: albuterol/salbutamol 90 mcg | Drug: Beclomethasone dipropionate MDI | Drug: Placebo MDI
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 4 Years to 11 Years
Trial Duration
- 12/01/2013 - 03/01/2016
Phase
- Phase 3
Study Type
Interventional
